Atlas Trials

Ultrahypofractionated Versus Normofractionated Sequential Boost After Whole-breast Radiation Therapy in Patients Treated With Breast-conserving Surgery for Breast Cancer

Clinical trial NCT07590505 · COMPLETED

Trial details

NCT number
NCT07590505
Sponsor
Cancer Research Antwerp
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2022-03-29
Primary completion
2025-11-28
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.